Skip to content
10-Q

Quarterly Report

Amphastar Pharmaceuticals, Inc. AMPH

0001297184-25-000064

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 45.95M sh
Shares Diluted Q3 2025 · Sep 30, 2025 47.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 48.57M sh
Shares Diluted Q3 2025 · Sep 30, 2024 51.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 52.31M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $55.07M
Stock Repurchased Q3 2025 · Sep 30, 2024 $43.46M
Capex Q3 2025 · Sep 30, 2025 $26.61M
Capex Q3 2025 · Sep 30, 2024 $28.63M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $123.25M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $184.36M
Short Term Investments Q3 2025 · Sep 30, 2025 $59.94M
Short Term Investments Q3 2025 · Dec 31, 2024 $70.04M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $216.27M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $151.61M
Current Liabilities Q3 2025 · Sep 30, 2025 $205.23M
Current Liabilities Q3 2025 · Dec 31, 2024 $173.76M
Total Liabilities Q3 2025 · Sep 30, 2025 $889.48M
Total Liabilities Q3 2025 · Dec 31, 2024 $845.17M
Current Assets Q3 2025 · Sep 30, 2025 $639.47M
Current Assets Q3 2025 · Dec 31, 2024 $534.07M
Total Assets Q3 2025 · Sep 30, 2025 $1.67B
Total Assets Q3 2025 · Dec 31, 2024 $1.58B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.37
Eps Diluted Q3 2025 · Sep 30, 2025 $1.52
Eps Diluted Q3 2025 · Sep 30, 2024 $0.78
Eps Diluted Q3 2025 · Sep 30, 2024 $2.32
Eps Basic Q3 2025 · Sep 30, 2025 $0.38
Eps Basic Q3 2025 · Sep 30, 2025 $1.57
Eps Basic Q3 2025 · Sep 30, 2024 $0.83
Eps Basic Q3 2025 · Sep 30, 2024 $2.50
Sga Expense Q3 2025 · Sep 30, 2025 $39.47M
Sga Expense Q3 2025 · Sep 30, 2025 $69.45M
Sga Expense Q3 2025 · Sep 30, 2024 $14.82M
Sga Expense Q3 2025 · Sep 30, 2024 $43.78M
Rd Expense Q3 2025 · Sep 30, 2025 $22.35M
Rd Expense Q3 2025 · Sep 30, 2025 $62.53M
Rd Expense Q3 2025 · Sep 30, 2024 $21.08M
Rd Expense Q3 2025 · Sep 30, 2024 $55.77M
Net Income Q3 2025 · Sep 30, 2025 $17.35M
Net Income Q3 2025 · Sep 30, 2025 $73.67M
Net Income Q3 2025 · Jun 30, 2025 $31.03M
Net Income Q3 2025 · Mar 31, 2025 $25.29M
Net Income Q3 2025 · Sep 30, 2024 $40.43M
Net Income Q3 2025 · Sep 30, 2024 $121.56M
Net Income Q3 2025 · Jun 30, 2024 $37.95M
Net Income Q3 2025 · Mar 31, 2024 $43.18M
Operating Income Q3 2025 · Sep 30, 2025 $25.32M
Operating Income Q3 2025 · Sep 30, 2025 $104.8M
Operating Income Q3 2025 · Sep 30, 2024 $57.05M
Operating Income Q3 2025 · Sep 30, 2024 $160.28M
Gross Profit Q3 2025 · Sep 30, 2025 $98.65M
Gross Profit Q3 2025 · Sep 30, 2025 $270.39M
Gross Profit Q3 2025 · Sep 30, 2024 $101.94M
Gross Profit Q3 2025 · Sep 30, 2024 $287.21M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $93.19M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $266.4M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $89.27M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $258.24M
Revenue Q3 2025 · Sep 30, 2025 $191.84M
Revenue Q3 2025 · Sep 30, 2025 $536.78M
Revenue Q3 2025 · Sep 30, 2024 $191.21M
Revenue Q3 2025 · Sep 30, 2024 $545.44M